mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |